Transcranial Magnetic Stimulation to Improve Speech in Aphasia
Aphasia, Cerebrovascular Stroke
About this trial
This is an interventional treatment trial for Aphasia focused on measuring Transcranial Magnetic Stimulation, Repetitive, TMS, Treat Naming, Aphasia, Chronic Stroke, Randomized, Controlled Trial
Eligibility Criteria
Inclusion Criteria:
- Right Handed
- Single, Left Hemisphere Cerebrovascular Stroke
- Must be at least 6 months poststroke onset
- Native Speaker of English
- Clinical Diagnosis of Aphasia
Exclusion Criteria:
- Intracranial metallic body from prior neurosurgical procedure
- Implanted metallic devices: pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit or ventriculoperitoneal shunt
- Past history of seizure within 1 year
- Pregnancy
- History of substance abuse within last 6 months
Sites / Locations
- VA Boston Healthcare System, Jamaica Plain Campus, Boston University Aphasia Research Center (12-A), 150 So. Huntington Ave.
- Berenson-Allen Center for Noninvasive Brain Stimulation, 330 Brookline Ave, Kirstein Bldg., Dept. of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School
- Department of Neurology, Hospital of the University of Pennsylvania, 3 W. Gates Bldg.
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Real rTMS
Sham rTMS
These patients receive a series of 10 Real Transcranial Magnetic Stimulation, Repetitive (rTMS), treatments, only. There is pre-testing, and post-testing at 2 months after the last Real rTMS treatment.
Patients receive a series of 10 Sham Transcranial Magnetic Stimulation, Repetitive (rTMS) treatments, followed by a series of 10 Real rTMS treatments. Sham rTMS treatments are identical to the Real rTMS treatments, however, no magnetic pulse is released. There is pre-testing, and post-testing at 2 months after the last Sham rTMS treatment.